Empowering dentists to reduce opioid prescriptions to young people
Empowering dentists to reduce opioid prescriptions to young people
批准号:
10620388
负责人:
Douglas Oyler
金额:
$58.02万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-01-01 至 2023-12-31
关键词:
Academic DetailingAcetaminophenAcuteAcute pain managementAddressAdolescent and Young AdultAmericanAnalgesicsArchitectureBehaviorBullaClinicClinical Trials DesignCluster randomized trialCommunity TrialCountryDataDecision MakingDentalDental CareDental ClinicsDental General PracticeDentistryDentistsDiseaseDoseDrug MonitoringDrug PrescriptionsEducationEducational MaterialsEffectivenessElectronic Health RecordEnrollmentEnvironmental Risk FactorGoalsIbuprofenIndividualInterventionInterviewKentuckyKnowledgeMeasuresModelingMorphineMotivationNational Institute of Dental and Craniofacial ResearchOpioidOral SurgeonOral Surgical ProceduresOutcomeOverdosePainPain interferencePain managementPatient EducationPatientsPersonsPharmaceutical PreparationsProcessProviderPublic HealthRecommendationReportingResearchRiskSafetySiteStandardizationSubstance Use DisorderSurveysTestingTooth ExtractionToothacheUnited StatesUse EffectivenessWorkacademic interventionclinical decision supportdental agenteffective interventioneffectiveness evaluationempowermentevidence based guidelinesexperiencehealth recordhigh riskhigh risk populationimplementation evaluationimplementation interventionimplementation outcomesimplementation scienceimprovedinnovationmembermilligrammulti-component interventionmultidisciplinarynon-opioid analgesicnovelnovel strategiesopioid exposureopioid misuseopioid usepillprescription opioidprescription opioid misuseprimary endpointprovider factorsrecruitsatisfactionsecondary endpointtherapy design
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Dentists are the leading prescriber of opioids to adolescents and young adults (AYAs), even though opioid use
after tooth extraction is not associated with improved pain control or satisfaction. In AYAs, an opioid prescription
after a dental procedure increases the risk of opioid misuse, use disorder, and overdose. The long-term goal of
this project is to develop a framework to reduce opioid prescriptions to AYAs for treatment of acute dental pain.
The objective of this proposal is to establish the effectiveness of a multicomponent intervention at reducing
dental opioid prescription rates after tooth extraction in AYAs. Our central hypothesis is that a multicomponent
intervention is required to produce significant reductions in post-extraction opioid prescriptions to AYAs. The
rationale underlying this proposal is that a multicomponent intervention will address provider knowledge,
motivation, and choice architecture better than a single-component strategy; will engage and educate patients;
and will provide a physical item for distribution instead of an opioid prescription. We will test this hypothesis by
pursuing four specific aims: in the UG3 period, 1) complete requisite preliminary work to test a new approach
to manage acute pain following dental treatment, and in the UH3 period: 1) establish effectiveness of a novel
educational and drug-dispensing approach using academic detailing, patient education, and blister-packaged
non-opioid analgesics to reduce opioid prescriptions following tooth extraction among AYAs; 2) examine key
implementation outcomes of the intervention designed to modify dental professional decision-making behaviors;
and 3) assess patient-reported pain management, analgesic use, and drug disposal after tooth extraction. To
accomplish these aims, we propose a stepped wedge cluster randomized trial of community and academic clinics
across Kentucky using an innovative intervention of one-on-one provider education plus provider distribution of
patient education materials and standardized blister packs containing acetaminophen and ibuprofen. This study
will be conducted across at least 10 of the largest oral surgery practices in Kentucky, enrolling at least 27
providers expected to perform tooth extractions on over 40,000 AYAs. We will assess effectiveness using a
primary endpoint of the patient-level binary indicator of being prescribed an opioid. Secondary endpoints
include intervention acceptability, appropriateness, feasibility, and fidelity (UH3 aim 2); and patient-reported pain,
pain interference, analgesic use, and drug disposal (UH3 aim 3). The proposed research is significant because
it will provide a framework for wide-scale implementation of interventions to modify dental decision-making
behaviors towards evidence-based recommendations for acute pain management, resulting in a reduction in
opioid prescription rates after tooth extraction. The expected outcome is a framework to implement effective
interventions to reduce dental opioid prescribing to AYAs. The results will have a positive impact immediately
because they will limit unnecessary opioid exposure, and long-term because they will help dentistry build a
framework for reducing the impact of substance use disorders across the United States.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding the Association between Sublingual Buprenorphine and Oral Health Outcomes
-
批准号:10765299
-
项目类别:
-
资助金额:$135.65万
-
财政年份:2023
-
负责人:Douglas Oyler
-
依托单位:
国内基金
海外基金
SirT1在Acetaminophen诱发的药物性肝损伤中的作用及机制
-
批准号:81100281
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:黄卫锋
-
依托单位: